Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment
2023 · Journal of Clinical Investigation · 205 citations
https://doi.org/10.1172/jci163447
C
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
164
Papers
1.9K
Citations
18
h-index
28
i10-index
Crismita Dmello is an academic researcher from Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Metal complexes synthesis and properties & Ultrasound and Hyperthermia Applications. The author has an h-index of 18, co-authored 140 publications.
ORCID: 0000-0002-1688-9663Papers by this author
worksUltrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas
2024 · Nature Communications · 75 citations
https://doi.org/10.1038/s41467-024-48326-w
Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade
2023 · Nature Communications · 41 citations
https://doi.org/10.1038/s41467-023-36878-2
STING agonist 8803 reprograms the immune microenvironment and increases survival in preclinical models of glioblastoma
2024 · Journal of Clinical Investigation · 37 citations
https://doi.org/10.1172/jci175033
Smart Nanoscale Extracellular Vesicles in the Brain: Unveiling their Biology, Diagnostic Potential, and Therapeutic Applications
2024 · ACS Applied Materials & Interfaces · 18 citations
https://doi.org/10.1021/acsami.3c16839
Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy?
2024 · Neuro-Oncology · 8 citations
https://doi.org/10.1093/neuonc/noae193
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat